Baxalta

650 E Kendall Street
Cambridge
Massachusetts
United States

Show jobs for this employer

About Baxalta

Baxalta Incorporated (NYSE: BXLT) is a $6 billion global biopharmaceutical leader developing, manufacturing and commercializing therapies for orphan diseases and underserved conditions in hematology, oncology and immunology. Driven by passion to make a meaningful impact on patients’ lives, Baxalta’s broad and diverse pipeline includes biologics with novel mechanisms and advanced technology platforms such as gene therapy. The Baxalta Global Innovation and R&D Center is located in Cambridge, Massachusetts. Launched in 2015 following separation from Baxter International, Baxalta’s heritage in biopharmaceuticals spans decades. Baxalta’s therapies are available in more than 100 countries and it has advanced biological manufacturing operations across 12 facilities, including state-of-the-art recombinant production and plasma fractionation. Headquartered in Northern Illinois, Baxalta employs 16,000 employees worldwide.
YEAR FOUNDED:
2015
LEADERSHIP:
CEO: Ludwig Hantson
CFO: Robert Hombach
CSO (Scientific): John Orloff
JOBS:
Please click here for Baxalta job opportunitites.
CLINICAL TRIAL:
Please click here for clinical trial information.

PRODUCTS: All Products
FOLLOW BAXALTA :

114 articles with Baxalta